U.S. FDA guidance on biosimilars may be imminent

* Long-awaited rules may pave way for U.S. biosimilar market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.